Copyright Reports & Markets. All rights reserved.

Global Placental Stem Cell Therapy Market Size, Status and Forecast 2021-2027

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Placental Stem Cell Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Hematologic Malignancies and Disorders
    • 1.2.3 Congenital Immunodeficiency Disorders
    • 1.2.4 Metabolic Disorders
    • 1.2.5 Neurological Disorders
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Placental Stem Cell Therapy Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals and Specialty Clinics
    • 1.3.3 Clinical Research Organizations
    • 1.3.4 Research Institutes and Academies
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Placental Stem Cell Therapy Market Perspective (2016-2027)
  • 2.2 Placental Stem Cell Therapy Growth Trends by Regions
    • 2.2.1 Placental Stem Cell Therapy Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Placental Stem Cell Therapy Historic Market Share by Regions (2016-2021)
    • 2.2.3 Placental Stem Cell Therapy Forecasted Market Size by Regions (2022-2027)
  • 2.3 Placental Stem Cell Therapy Industry Dynamic
    • 2.3.1 Placental Stem Cell Therapy Market Trends
    • 2.3.2 Placental Stem Cell Therapy Market Drivers
    • 2.3.3 Placental Stem Cell Therapy Market Challenges
    • 2.3.4 Placental Stem Cell Therapy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Placental Stem Cell Therapy Players by Revenue
    • 3.1.1 Global Top Placental Stem Cell Therapy Players by Revenue (2016-2021)
    • 3.1.2 Global Placental Stem Cell Therapy Revenue Market Share by Players (2016-2021)
  • 3.2 Global Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Placental Stem Cell Therapy Revenue
  • 3.4 Global Placental Stem Cell Therapy Market Concentration Ratio
    • 3.4.1 Global Placental Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy Revenue in 2020
  • 3.5 Placental Stem Cell Therapy Key Players Head office and Area Served
  • 3.6 Key Players Placental Stem Cell Therapy Product Solution and Service
  • 3.7 Date of Enter into Placental Stem Cell Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Placental Stem Cell Therapy Breakdown Data by Type

  • 4.1 Global Placental Stem Cell Therapy Historic Market Size by Type (2016-2021)
  • 4.2 Global Placental Stem Cell Therapy Forecasted Market Size by Type (2022-2027)

5 Placental Stem Cell Therapy Breakdown Data by Application

  • 5.1 Global Placental Stem Cell Therapy Historic Market Size by Application (2016-2021)
  • 5.2 Global Placental Stem Cell Therapy Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Placental Stem Cell Therapy Market Size (2016-2027)
  • 6.2 North America Placental Stem Cell Therapy Market Size by Type
    • 6.2.1 North America Placental Stem Cell Therapy Market Size by Type (2016-2021)
    • 6.2.2 North America Placental Stem Cell Therapy Market Size by Type (2022-2027)
    • 6.2.3 North America Placental Stem Cell Therapy Market Size by Type (2016-2027)
  • 6.3 North America Placental Stem Cell Therapy Market Size by Application
    • 6.3.1 North America Placental Stem Cell Therapy Market Size by Application (2016-2021)
    • 6.3.2 North America Placental Stem Cell Therapy Market Size by Application (2022-2027)
    • 6.3.3 North America Placental Stem Cell Therapy Market Size by Application (2016-2027)
  • 6.4 North America Placental Stem Cell Therapy Market Size by Country
    • 6.4.1 North America Placental Stem Cell Therapy Market Size by Country (2016-2021)
    • 6.4.2 North America Placental Stem Cell Therapy Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Placental Stem Cell Therapy Market Size (2016-2027)
  • 7.2 Europe Placental Stem Cell Therapy Market Size by Type
    • 7.2.1 Europe Placental Stem Cell Therapy Market Size by Type (2016-2021)
    • 7.2.2 Europe Placental Stem Cell Therapy Market Size by Type (2022-2027)
    • 7.2.3 Europe Placental Stem Cell Therapy Market Size by Type (2016-2027)
  • 7.3 Europe Placental Stem Cell Therapy Market Size by Application
    • 7.3.1 Europe Placental Stem Cell Therapy Market Size by Application (2016-2021)
    • 7.3.2 Europe Placental Stem Cell Therapy Market Size by Application (2022-2027)
    • 7.3.3 Europe Placental Stem Cell Therapy Market Size by Application (2016-2027)
  • 7.4 Europe Placental Stem Cell Therapy Market Size by Country
    • 7.4.1 Europe Placental Stem Cell Therapy Market Size by Country (2016-2021)
    • 7.4.2 Europe Placental Stem Cell Therapy Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Placental Stem Cell Therapy Market Size (2016-2027)
  • 8.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Type
    • 8.2.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Application
    • 8.3.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Placental Stem Cell Therapy Market Size by Region
    • 8.4.1 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Placental Stem Cell Therapy Market Size (2016-2027)
  • 9.2 Latin America Placental Stem Cell Therapy Market Size by Type
    • 9.2.1 Latin America Placental Stem Cell Therapy Market Size by Type (2016-2021)
    • 9.2.2 Latin America Placental Stem Cell Therapy Market Size by Type (2022-2027)
    • 9.2.3 Latin America Placental Stem Cell Therapy Market Size by Type (2016-2027)
  • 9.3 Latin America Placental Stem Cell Therapy Market Size by Application
    • 9.3.1 Latin America Placental Stem Cell Therapy Market Size by Application (2016-2021)
    • 9.3.2 Latin America Placental Stem Cell Therapy Market Size by Application (2022-2027)
    • 9.3.3 Latin America Placental Stem Cell Therapy Market Size by Application (2016-2027)
  • 9.4 Latin America Placental Stem Cell Therapy Market Size by Country
    • 9.4.1 Latin America Placental Stem Cell Therapy Market Size by Country (2016-2021)
    • 9.4.2 Latin America Placental Stem Cell Therapy Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Placental Stem Cell Therapy Market Size (2016-2027)
  • 10.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Type
    • 10.2.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Application
    • 10.3.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Placental Stem Cell Therapy Market Size by Country
    • 10.4.1 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Lifebank Stem Cell Banking
    • 11.1.1 Lifebank Stem Cell Banking Company Details
    • 11.1.2 Lifebank Stem Cell Banking Business Overview
    • 11.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Introduction
    • 11.1.4 Lifebank Stem Cell Banking Revenue in Placental Stem Cell Therapy Business (2016-2021)
    • 11.1.5 Lifebank Stem Cell Banking Recent Development
  • 11.2 Cynata
    • 11.2.1 Cynata Company Details
    • 11.2.2 Cynata Business Overview
    • 11.2.3 Cynata Placental Stem Cell Therapy Introduction
    • 11.2.4 Cynata Revenue in Placental Stem Cell Therapy Business (2016-2021)
    • 11.2.5 Cynata Recent Development
  • 11.3 Celularity
    • 11.3.1 Celularity Company Details
    • 11.3.2 Celularity Business Overview
    • 11.3.3 Celularity Placental Stem Cell Therapy Introduction
    • 11.3.4 Celularity Revenue in Placental Stem Cell Therapy Business (2016-2021)
    • 11.3.5 Celularity Recent Development
  • 11.4 Athersys
    • 11.4.1 Athersys Company Details
    • 11.4.2 Athersys Business Overview
    • 11.4.3 Athersys Placental Stem Cell Therapy Introduction
    • 11.4.4 Athersys Revenue in Placental Stem Cell Therapy Business (2016-2021)
    • 11.4.5 Athersys Recent Development
  • 11.5 Americord Registry
    • 11.5.1 Americord Registry Company Details
    • 11.5.2 Americord Registry Business Overview
    • 11.5.3 Americord Registry Placental Stem Cell Therapy Introduction
    • 11.5.4 Americord Registry Revenue in Placental Stem Cell Therapy Business (2016-2021)
    • 11.5.5 Americord Registry Recent Development
  • 11.6 ReNeuron Group
    • 11.6.1 ReNeuron Group Company Details
    • 11.6.2 ReNeuron Group Business Overview
    • 11.6.3 ReNeuron Group Placental Stem Cell Therapy Introduction
    • 11.6.4 ReNeuron Group Revenue in Placental Stem Cell Therapy Business (2016-2021)
    • 11.6.5 ReNeuron Group Recent Development
  • 11.7 ReeLabs
    • 11.7.1 ReeLabs Company Details
    • 11.7.2 ReeLabs Business Overview
    • 11.7.3 ReeLabs Placental Stem Cell Therapy Introduction
    • 11.7.4 ReeLabs Revenue in Placental Stem Cell Therapy Business (2016-2021)
    • 11.7.5 ReeLabs Recent Development
  • 11.8 Mesoblast
    • 11.8.1 Mesoblast Company Details
    • 11.8.2 Mesoblast Business Overview
    • 11.8.3 Mesoblast Placental Stem Cell Therapy Introduction
    • 11.8.4 Mesoblast Revenue in Placental Stem Cell Therapy Business (2016-2021)
    • 11.8.5 Mesoblast Recent Development
  • 11.9 Pluristem Therapeutics
    • 11.9.1 Pluristem Therapeutics Company Details
    • 11.9.2 Pluristem Therapeutics Business Overview
    • 11.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Introduction
    • 11.9.4 Pluristem Therapeutics Revenue in Placental Stem Cell Therapy Business (2016-2021)
    • 11.9.5 Pluristem Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Placental Stem Cell Therapy Scope and Market Size
    Placental Stem Cell Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Placental Stem Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Hematologic Malignancies and Disorders
    Congenital Immunodeficiency Disorders
    Metabolic Disorders
    Neurological Disorders
    Others

    Segment by Application
    Hospitals and Specialty Clinics
    Clinical Research Organizations
    Research Institutes and Academies
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Lifebank Stem Cell Banking
    Cynata
    Celularity
    Athersys
    Americord Registry
    ReNeuron Group
    ReeLabs
    Mesoblast
    Pluristem Therapeutics

    Buy now